Vancomycin hydrochloride

General description
Vancomycin hydrochloride is a glycopeptide antibiotic effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It inhibits cell wall biosynthesis by binding to D-Ala-D-Ala termini of cell wall precursors. The USP standard provides a validated benchmark for microbiological assays and chromatographic identification techniques.

The USP biologics antibiotics category includes a wide range of antimicrobial agents that are essential in treating bacterial infections. These antibiotics are derived from various natural sources or synthesized to combat specific pathogens effectively. The USP provides comprehensive standards, reference materials, and analytical procedures to ensure the identity, quality, purity, and consistency of antibiotic therapeutics throughout their lifecycle.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Application
Vancomycin hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
Vancomycin Hydrochloride Capsules
Vancomycin Hydrochloride for Injection
Vancomycin Hydrochloride for Oral Solution
Vancomycin Injection
Vancomycin
Packaging
4 vials, each vial contains 99,300 mcg of vancomycin activity
Other Notes
Sales restrictions may apply.
This product is part of the USP Biologics program.